HCmed Innovations Co (TPE:6934) Current Ratio: 4.81 (As of Dec. 2025) — 16% Below Median


TPE:6934 HCmed Innovations Co Ltd TPE:6934
11 GF Score
Price NT$68.00
! 4 Warning Signs
View Full Analysis

What is HCmed Innovations Co Current Ratio?

HCmed Innovations Co TPE:6934 -2.16% 11 Current Ratio is 4.81 as of Dec. 2025, which is 16% below its 10-year median of 5.72. GuruFocus rates TPE:6934 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 854 Medical Devices & Instruments companies, HCmed Innovations Co ranks better than 76.23% on this metric.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. HCmed Innovations Co's current ratio for the quarter that ended in Dec. 2025 was 4.81.

HCmed Innovations Co has a current ratio of 4.81. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

The historical rank and industry rank for HCmed Innovations Co's Current Ratio or its related term are showing as below:

TPE:6934' s Current Ratio Range Over the Past 10 Years
Min: 3.12   Med: 5.72   Max: 6.52
Current: 4.81

During the past 5 years, HCmed Innovations Co's highest Current Ratio was 6.52. The lowest was 3.12. And the median was 5.72.

TPE:6934's Current Ratio is ranked better than
76.23% of 854 companies
in the Medical Devices & Instruments industry
Industry Median: 2.49 vs TPE:6934: 4.81

HCmed Innovations Co  (TPE:6934) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


HCmed Innovations Co Current Ratio Related Terms


HCmed Innovations Co Current Ratio Historical Data

* Premium members only.

The historical data trend for HCmed Innovations Co's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HCmed Innovations Co Current Ratio Chart

HCmed Innovations Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Current Ratio
3.12 6.52 6.27 5.72 4.81

HCmed Innovations Co Quarterly Data
Dec21 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 5.72 11.14 6.86 4.81

TPE:6934 vs ABT, SYK, MDT: Current Ratio Comparison

For the Medical Devices subindustry, HCmed Innovations Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HCmed Innovations Co Current Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HCmed Innovations Co's Current Ratio distribution charts can be found below:

* The bar in red indicates where HCmed Innovations Co's Current Ratio falls into.


TPE:6934
11GF Score
HCmed Innovations Co Ltd TPE:6934
Current Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HCmed Innovations Co Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

HCmed Innovations Co's Current Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Current Ratio (A: Dec. 2025 )=Total Current Assets (A: Dec. 2025 )/Total Current Liabilities (A: Dec. 2025 )
=287.555/59.769
=4.81

HCmed Innovations Co's Current Ratio for the quarter that ended in Dec. 2025 is calculated as

Current Ratio (Q: Dec. 2025 )=Total Current Assets (Q: Dec. 2025 )/Total Current Liabilities (Q: Dec. 2025 )
=287.555/59.769
=4.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 4.81 mean?
HCmed Innovations Co (TPE:6934) has a Current Ratio of 4.81 as of Dec. 2025. This is 16% below median its historical median of 5.72. Over the past decade, HCmed Innovations Co's Current Ratio has ranged from 3.12 to 6.52. According to the industry distribution chart, HCmed Innovations Co ranks #203 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 23.8%.
Is HCmed Innovations Co's Current Ratio too high?
HCmed Innovations Co's current Current Ratio of 4.81 is 16% below median its 10-year median of 5.72. Over the past 10 years, this metric has ranged from a low of 3.12 to a high of 6.52. The Medical Devices & Instruments industry median Current Ratio is 2.49. HCmed Innovations Co's value of 4.81 is 93.2% above this industry median. Based on the distribution chart, HCmed Innovations Co ranks #203 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, HCmed Innovations Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does HCmed Innovations Co's Current Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, HCmed Innovations Co ranks #203 out of 854 companies for Current Ratio. This places HCmed Innovations Co in the top 24% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.49. HCmed Innovations Co's value of 4.81 is 93.2% above this benchmark. Historically, HCmed Innovations Co's own Current Ratio has ranged from 3.12 to 6.52 over the past decade. While the company's 10-year median is 5.72 vs. the industry median of 2.49, HCmed Innovations Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.49, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HCmed Innovations Co's current Current Ratio of 4.81 is 93.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HCmed Innovations Co's current Current Ratio is 4.81, which is 16% below median its own 10-year median of 5.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HCmed Innovations Co stock overvalued right now?
HCmed Innovations Co (TPE:6934) has a current Current Ratio of 4.81. The current Current Ratio is 4.81, which is 16% below median its 10-year median of 5.72 and 93.2% above the Medical Devices & Instruments industry median of 2.49. HCmed Innovations Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For HCmed Innovations Co (TPE:6934), the current Current Ratio is 4.81 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HCmed Innovations Co Business Description

Address Dunhua S. Road, Rm.B, 10th floor., No.319, Sec.2, Taipei, TWN, 106033
HCmed Innovations Co Ltd is engaged in designing, developing, manufacturing and selling drug delivery system. It is focused on inhalation therapy to create integrated drug nebulizer combination products featuring nebulization therapeutic drugs that include small molecule synthetics and large molecule biologics, as either solutions, suspensions, and even difficult-to-deliver high viscosity drugs. Its product includes Pulmogine. Geographically, the company operates in America, Europe, Asian and African regions.
11GF Score

Get the complete analysis for TPE:6934

Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$68.00
Price